We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

281 hedge funds and large institutions have $7.27B invested in PHARMACYCLICS INC in 2014 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 95 increasing their positions, 93 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 19

12% more funds holding

Funds holding: 250281 (+31)

8% more capital invested

Capital invested by funds: $6.76B → $7.27B (+$515M)

2% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 93

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

24% less call options, than puts

Call options by funds: $100M | Put options by funds: $132M

Holders
281
Holders Change
+31
Holders Change %
+12.4%
% of All Funds
7.5%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.21%
New
53
Increased
95
Reduced
93
Closed
19
Calls
$100M
Puts
$132M
Net Calls
-$32.4M
Net Calls Change
+$71.2M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$1.21B +$7.74M +60,592 +0.6%
BBA
2
Baker Bros. Advisors
New York
$1.12B -$67.4M -527,368 -5%
Ameriprise
3
Ameriprise
Minnesota
$607M +$59.4M +464,481 +10%
JHIU
4
Janus Henderson Investors US
Colorado
$596M +$136M +1,065,780 +28%
Vanguard Group
5
Vanguard Group
Pennsylvania
$443M +$13.6M +106,620 +3%
Primecap Management
6
Primecap Management
California
$282M -$63.9K -500 -0%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$244M -$678K -5,306 -0.3%
Capital World Investors
8
Capital World Investors
California
$243M -$62.9M -492,555 -20%
BIT
9
BlackRock Institutional Trust
California
$188M +$487K +3,814 +0.2%
BFA
10
BlackRock Fund Advisors
California
$170M +$116M +911,340 +190%
State Street
11
State Street
Massachusetts
$139M -$1.61M -12,633 -1%
FAM
12
Fred Alger Management
New York
$116M -$9.13M -71,403 -7%
Federated Hermes
13
Federated Hermes
Pennsylvania
$102M +$1.3M +10,151 +1%
First Trust Advisors
14
First Trust Advisors
Illinois
$101M +$13.5M +105,305 +15%
BB
15
BB Biotech
Switzerland
$89.4M
MAA
16
Managed Account Advisors
New Jersey
$80.6M +$7.46M +58,339 +10%
Norges Bank
17
Norges Bank
Norway
$71.4M
Morgan Stanley
18
Morgan Stanley
New York
$65M -$3.68M -28,816 -5%
UBS AM
19
UBS AM
Illinois
$50.5M +$1.24M +9,665 +2%
CCM
20
Cornerstone Capital Management
Minnesota
$49.1M -$37.1M -290,007 -42%
Deutsche Bank
21
Deutsche Bank
Germany
$47.9M +$15.8M +123,450 +46%
AllianceBernstein
22
AllianceBernstein
Tennessee
$47.8M +$172K +1,344 +0.3%
TCIM
23
TIAA CREF Investment Management
New York
$45.9M +$8.07M +63,143 +20%
Northern Trust
24
Northern Trust
Illinois
$43.9M -$1.29M -10,109 -3%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$40.6M -$599K -4,690 -1%

PCYC Hedge Fund Activity: Q4 2014 in Review

281 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q4 2014, worth a combined $7.27B — up 7.6% from $6.76B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new PCYC positions and 19 closed out — a net gain of 34 holders — while 95 added to existing stakes and 93 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $136M. The largest seller was Baker Bros. Advisors, cutting an estimated $67.4M.

  • 281 institutional investors held PHARMACYCLICS INC (PCYC) as of Q4 2014, up from 250 in Q3 2014.
  • Funds reported $7.27B of PHARMACYCLICS INC stock for Q4 2014, up 7.6% quarter-over-quarter.
  • 53 funds opened new PHARMACYCLICS INC positions in Q4 2014 and 19 closed out, a net change of +34 holders.
  • The largest PHARMACYCLICS INC buyer in Q4 2014 was Janus Henderson Investors US, an estimated $136M added.
  • The largest PHARMACYCLICS INC seller in Q4 2014 was Baker Bros. Advisors, an estimated $67.4M sold.

Based on aggregated 13F filings for Q4 2014.